Published on Sunday February 06, 2022
We are working on the following new projects:
- We were awarded with two phase IV full-service trials of Nimesulide.
- We signed four new contracts for BE trials with our Russian sponsor (INN Hymecromone, Apixaban, Dapagliflozinum, Rosuvastatin).
- Smooth signed contracts for two Paliperidone trials.
- We signed a contract for medical writing for a cell therapy trial. We are happy to be involved in such a project because there is just one cell product under clinical development in Russia.
We are happy to reach the following milestones in our projects:
- The enrollment is finished in the Covid-19 vaccine trial. 5000 subjects were randomized for less than 2 months.
- 50% of the sites were open and 100 subjects were enrolled in the observational program with polyvitamins.